Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-31 Purchase |
2023-11-02 9:21 pm |
Eiger BioPharmaceuticals Inc. | EIGR | KAYNE RICHARD A 10% Owner |
278,239 | $0.2617 | $72,815 | 5,375,225 (Indirect) |
View |
| 2023-10-31 Purchase |
2023-11-02 9:14 pm |
Eiger BioPharmaceuticals Inc. | EIGR | KAWAS LEEN 10% Owner |
24,332 | $0.26199 | $6,375 | 4,391,432 (Indirect) |
View |
| 2023-03-17 Sale |
2023-03-21 9:00 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer |
4,395 | $1.0703 | $4,704 | 56,073 (Direct) |
View |
| 2023-01-23 Purchase |
2023-01-25 8:54 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Dietz Thomas John Director |
50,000 | $1.4316 | $71,580 | 71,000 (Indirect Direct) |
View |
| 2022-12-29 Sale |
2023-01-03 8:30 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Murray Christine Director |
5,000 | $1.2208 | $6,104 | 11,000 (Direct) |
View |
| 2022-12-22 Sale |
2022-12-27 5:31 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Dietz Thomas John Director |
22,500 | $1.169 | $26,303 | 21,000 (Direct) |
View |
| 2022-12-22 Purchase |
2022-12-27 5:31 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Glenn Jeffrey S Director |
100,000 | $1.2795 | $127,950 | 338,879 (Indirect Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 5:36 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Apelian David Director |
5,000 | $9.8061 | $49,031 | 11,000 (Direct) |
View |
| 2022-03-14 Sale |
2022-03-14 9:22 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer |
2,266 | $5.5973 | $12,683 | 41,566 (Direct) |
View |
| 2022-03-14 Sale |
2022-03-14 9:21 pm |
Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer |
1,657 | $5.5973 | $9,275 | 60,468 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2023-10-30 4:53 pm |
N/A N/A |
Eiger BioPharmaceuticals Inc. | EIGR | KAYNE RICHARD A 10% Owner |
0 | $0 | 5,096,986 (Indirect) |
View |
Ownership |
2023-10-30 4:51 pm |
N/A N/A |
Eiger BioPharmaceuticals Inc. | EIGR | KAWAS LEEN 10% Owner |
0 | $0 | 4,367,100 (Indirect) |
View |
| 2023-08-31 Option Award |
2023-09-05 9:38 pm |
N/A 2033-08-30 |
Eiger BioPharmaceuticals Inc. | EIGR | Choong Ingrid Chief Business Officer |
54,000 | $0 | 54,000 (Direct) |
View |
Ownership |
2023-09-05 9:35 pm |
N/A N/A |
Eiger BioPharmaceuticals Inc. | EIGR | Choong Ingrid Chief Business Officer |
0 | $0 | 446,191 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-06 5:37 pm |
N/A 2033-07-02 |
Eiger BioPharmaceuticals Inc. | EIGR | Apelian David CEO |
750,000 | $0 | 750,000 (Direct) |
View |
| 2023-04-30 Option Award |
2023-05-02 4:30 pm |
N/A 2033-04-29 |
Eiger BioPharmaceuticals Inc. | EIGR | Vollins James General Counsel |
120,000 | $0 | 120,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:50 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Sachdev Amit Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:50 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:50 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Murray Christine Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:50 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Glenn Jeffrey S Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:50 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Sablich Kim Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:49 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Kelly-Croswell Lisa Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:49 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer |
98,000 | $0 | 98,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:49 pm |
N/A 2033-02-28 |
Eiger BioPharmaceuticals Inc. | EIGR | Dietz Thomas John Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 9:12 pm |
N/A 2033-01-31 |
Eiger BioPharmaceuticals Inc. | EIGR | Apelian David Interim CEO |
170,000 | $0 | 170,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 9:25 pm |
N/A 2033-01-26 |
Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer |
31,500 | $0 | 31,500 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 9:15 pm |
N/A 2033-01-26 |
Eiger BioPharmaceuticals Inc. | EIGR | Atkisson Erik GC & Chief Compliance Officer |
26,750 | $0 | 26,750 (Direct) |
View |
| 2022-07-18 Option Award |
2022-07-19 7:02 pm |
N/A 2032-07-17 |
Eiger BioPharmaceuticals Inc. | EIGR | Kelly-Croswell Lisa Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:07 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Sachdev Amit Director |
18,000 | $0 | 28,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Sablich Kim Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer |
167,000 | $0 | 186,832 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Murray Christine Director |
18,000 | $0 | 28,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Mayer Eldon C. III Ex VP & Chief Commerc. Officer |
114,000 | $0 | 160,125 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Glenn Jeffrey S Director |
18,000 | $0 | 250,879 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Loh Evan Director |
18,000 | $0 | 26,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Dietz Thomas John Director |
30,000 | $0 | 67,500 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-11 9:06 pm |
N/A 2032-03-10 |
Eiger BioPharmaceuticals Inc. | EIGR | Cory David A President and CEO |
328,000 | $0 | 450,183 (Direct) |
View |